Vendome Acquisition Corp I（VNME）股票分析

AI 分析 of Vendome Acquisition Corp I (VNME)

持有

Currently, VNME is trading at $10.34, which is at its 52-week high of $10.34, indicating it may be overvalued at this price point. The RSI is at 59.82, suggesting it is approaching overbought territory. While the company has shown a positive trend with a 1-year change of +3.19%, the lack of significant net income and a forward P/E ratio of 0 indicates uncertainty about future profitability. The main risk is the high price-to-book ratio of 1074.59, which suggests that the stock is significantly overvalued compared to its book value. Overall, it may be prudent to hold off on buying until a more favorable entry point is identified.

估值指標

Vendome Acquisition Corp I（VNME）目前預期本益比為 0.00，5 年平均預期本益比為。

預期本益比

5 年均值 P/E

目前P/E

0.00

預期 EV/EBITDA

5 年均值 EV/EBITDA

目前EV/EBITDA

0.00

預期股價營收比

5 年均值 P/S

目前P/S

0.00

持有 VNME 的大戶

M

Magnetar Capital Partners, LP

+ 持有VNME

+1.44%

3個月報酬率

C

Centiva Capital, LP

+ 持有VNME

-5.26%

3個月報酬率

VNME 常見問題 —— 由 Alphio AI 解答

Vendome Acquisition Corporation I is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific Business Combination target, and the Company has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has no operations and has generated no revenues. It operates in the Financials sector.

Currently, VNME is trading at $10.34, which is at its 52-week high of $10.34, indicating it may be overvalued at this price point. The RSI is at 59.82, suggesting it is approaching overbought territory. While the company has shown a positive trend with a 1-year change of +3.19%, the lack of significant net income and a forward P/E ratio of 0 indicates uncertainty about future profitability. The main risk is the high price-to-book ratio of 1074.59, which suggests that the stock is significantly overvalued compared to its book value. Overall, it may be prudent to hold off on buying until a more favorable entry point is identified.